Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. T...
Q1 2026
May 8, 2026
FY 2025
Mar 31, 2026
Q4 2025
Q3 2025
Nov 7, 2025
Q1 2025
May 9, 2025